Erythromelalgia.

Area of Science:

• Medical Science
• Clinical Medicine
• Rare Diseases

Background:

• Erythromelalgia is a rare disorder characterized by intense burning pain, erythema, and increased skin temperature, primarily affecting extremities.
• It is classified as primary (spontaneous) or secondary (associated with other conditions like myeloproliferative disorders, autoimmune diseases, or diabetes).
• A common pathogenetic mechanism involves microvascular arteriovenous shunting, leading to characteristic symptoms.

Purpose of the Study:

• To review the etiological basis of erythromelalgia.
• To outline diagnostic approaches for erythromelalgia.
• To present current therapeutic strategies for managing erythromelalgia.

Main Methods:

• Literature review of etiological factors, diagnostic criteria, and treatment options for erythromelalgia.
• Synthesis of information on primary and secondary erythromelalgia.
• Compilation of commonly prescribed medications and their classes.

Main Results:

• Erythromelalgia diagnosis relies on medical history and clinical findings.
• A wide array of medications show potential efficacy, including aspirin, propranolol, clonazepam, antidepressants, anticonvulsants, calcium antagonists, and prostaglandins.
• While often chronic and disabling, some patients experience disease resolution over time.

Conclusions:

• Erythromelalgia presents diverse etiological origins but shares a common microvascular shunting mechanism.
• Effective management involves a combination of historical data, clinical assessment, and pharmacological interventions.
• Despite its chronic nature, therapeutic advancements offer improved quality of life and potential for remission.